These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 22018261)
41. Epidemiology of candidemia in NICE area, France: A five-year study of antifungal susceptibility and mortality. Vannini M; Emery S; Lieutier-Colas F; Legueult K; Mondain V; Retur N; Gastaud L; Pomares C; Hasseine L J Mycol Med; 2022 Mar; 32(1):101210. PubMed ID: 34768155 [TBL] [Abstract][Full Text] [Related]
42. Interaction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans. Louie A; Banerjee P; Drusano GL; Shayegani M; Miller MH Antimicrob Agents Chemother; 1999 Dec; 43(12):2841-7. PubMed ID: 10582869 [TBL] [Abstract][Full Text] [Related]
43. One case of Candidemia developed after surgery for tongue cancer in a young adult. Otsuru M; Aoki T; Ota Y; Karakida K; Yamazaki H; Sasaki M Tokai J Exp Clin Med; 2009 Dec; 34(4):152-5. PubMed ID: 21319016 [TBL] [Abstract][Full Text] [Related]
44. Antifungal catheter lock therapy for the management of a persistent Candida albicans bloodstream infection in an adult receiving hemodialysis. Paul DiMondi V; Townsend ML; Johnson M; Durkin M Pharmacotherapy; 2014 Jul; 34(7):e120-7. PubMed ID: 24782326 [TBL] [Abstract][Full Text] [Related]
45. Support for the EUCAST and revised CLSI fluconazole clinical breakpoints by Sensititre® YeastOne® for Candida albicans: a prospective observational cohort study. van Hal SJ; Chen SC; Sorrell TC; Ellis DH; Slavin M; Marriott DM J Antimicrob Chemother; 2014 Aug; 69(8):2210-4. PubMed ID: 24788656 [TBL] [Abstract][Full Text] [Related]
46. Candida norvegensis fungemia in a liver transplant recipient. Sanclemente G; Marco F; Cervera C; Hoyo I; Colmenero J; Pitart C; Almela M; Navasa M; Moreno A Rev Iberoam Micol; 2015; 32(2):115-7. PubMed ID: 24794213 [TBL] [Abstract][Full Text] [Related]
47. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU. Nolla-Salas J; Sitges-Serra A; León-Gil C; Martínez-González J; León-Regidor MA; Ibáñez-Lucía P; Torres-Rodríguez JM Intensive Care Med; 1997 Jan; 23(1):23-30. PubMed ID: 9037636 [TBL] [Abstract][Full Text] [Related]
49. Primary repair of dog bites to the face: 40 cases. Javaid M; Feldberg L; Gipson M J R Soc Med; 1998 Aug; 91(8):414-6. PubMed ID: 9816355 [TBL] [Abstract][Full Text] [Related]
50. The island nasolabial flap in philtrum reconstruction after bite avulsion: a case report. Bento M; Carmo L; Trigo M; Rebelo N; Garcia P J Plast Reconstr Aesthet Surg; 2009 Nov; 62(11):e487-9. PubMed ID: 19046664 [No Abstract] [Full Text] [Related]
51. Candida infections in non-neutropenic children after the neonatal period. Hacimustafaoglu M; Celebi S Expert Rev Anti Infect Ther; 2011 Oct; 9(10):923-40. PubMed ID: 21973304 [TBL] [Abstract][Full Text] [Related]
52. Comparison of the clinical risk factors between Candida albicans and Candida non-albicans species for bloodstream infection. Shigemura K; Osawa K; Jikimoto T; Yoshida H; Hayama B; Ohji G; Iwata K; Fujisawa M; Arakawa S J Antibiot (Tokyo); 2014 Apr; 67(4):311-4. PubMed ID: 24424346 [TBL] [Abstract][Full Text] [Related]
53. Prior colonisation with Candida species fails to guide empirical therapy for candidaemia in critically ill adults. Troughton JA; Browne G; McAuley DF; Walker MJ; Patterson CC; McMullan R J Infect; 2010 Nov; 61(5):403-9. PubMed ID: 20849877 [TBL] [Abstract][Full Text] [Related]
54. Treatment of a perforating thoracic bite wound in a dog with negative pressure wound therapy. Nolff MC; Pieper K; Meyer-Lindenberg A J Am Vet Med Assoc; 2016 Oct; 249(7):794-800. PubMed ID: 27654166 [TBL] [Abstract][Full Text] [Related]
55. Microvascular replantation of a composite facial avulsion in a 24-month-old child after dog bite. Macias D; Kwon DI; Walker PC; Peterson NR Microsurgery; 2018 Feb; 38(2):218-221. PubMed ID: 29230869 [TBL] [Abstract][Full Text] [Related]
57. Emerging issue of fluconazole-resistant candidemia in a tertiary care hospital of southern italy: time for antifungal stewardship program. Bavaro DF; Balena F; Ronga L; Signorile F; Romanelli F; Stolfa S; Sparapano E; De Carlo C; Mosca A; Monno L; Angarano G; Saracino A J Mycol Med; 2022 Mar; 32(1):101206. PubMed ID: 34624594 [TBL] [Abstract][Full Text] [Related]
58. Mechanisms of action of antimicrobial peptides ToAP2 and NDBP-5.7 against Candida albicans planktonic and biofilm cells. do Nascimento Dias J; de Souza Silva C; de Araújo AR; Souza JMT; de Holanda Veloso Júnior PH; Cabral WF; da Glória da Silva M; Eaton P; de Souza de Almeida Leite JR; Nicola AM; Albuquerque P; Silva-Pereira I Sci Rep; 2020 Jun; 10(1):10327. PubMed ID: 32587287 [TBL] [Abstract][Full Text] [Related]
59. Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans. Barker KS; Crisp S; Wiederhold N; Lewis RE; Bareither B; Eckstein J; Barbuch R; Bard M; Rogers PD J Antimicrob Chemother; 2004 Aug; 54(2):376-85. PubMed ID: 15201233 [TBL] [Abstract][Full Text] [Related]
60. Candida parapsilosis osteomyelitis following dog bite: a case report and review of the literature. Di Bari S; Gavaruzzi F; De Meo D; Cera G; Raponi G; Ceccarelli G; Villani C J Mycol Med; 2022 Mar; 32(1):101208. PubMed ID: 34758425 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]